13.05.2005 22:09:00
|
Millipore CFO at Banc of America Securities 2005 Healthcare Conference
Business Editors/Healthcare Editors
Banc of America Securities Healthcare Conference 2005
BILLERICA, Mass.--(BUSINESS WIRE)--May 13, 2005--Millipore Corporation (NYSE:MIL) announced today that Kathy Allen, Millipore's Chief Financial Officer, will be speaking at the Banc of America Securities 2005 Healthcare Conference on May 19th at 11:20am Pacific Time. The conference is being held at the Four Seasons Hotel in Las Vegas, NV. Ms. Allen's presentation will be webcast and available for viewing live and after the conference. You can access the webcast from the Millipore home page, www.millipore.com. You can also access the webcast at this web site: http://www.veracast.com/webcasts/bas/healthcare05/id69306571.cfm
About Millipore
Millipore is a multinational bioscience company that provides technologies, tools and services for the discovery, development and production of new therapeutic drugs. It serves the life science research, biotechnology and pharmaceutical industries. For more information about Millipore visit www.millipore.com.
--30--JS/bo*
CONTACT: Millipore Investor Contact Geoffrey Helliwell, 978-715-1041 or 800-225-3384 Geoffrey_Helliwell@Millipore.com or Millipore Media Contact Thomas Anderson, 978-715-1043 or 800-225-3384 Thomas_Anderson@Millipore.com
KEYWORD: MASSACHUSETTS TRACK INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BIOTECHNOLOGY TRADESHOW SOURCE: Millipore
Copyright Business Wire 2005
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merck KGaAmehr Nachrichten
31.01.25 |
Börse Frankfurt in Grün: LUS-DAX legt letztendlich zu (finanzen.at) | |
31.01.25 |
Börse Frankfurt: DAX fällt zum Handelsende (finanzen.at) | |
31.01.25 |
Starker Wochentag in Frankfurt: Börsianer lassen LUS-DAX am Freitagnachmittag steigen (finanzen.at) | |
31.01.25 |
Handel in Frankfurt: DAX nachmittags mit Zuschlägen (finanzen.at) | |
31.01.25 |
ANALYSE-FLASH: Deutsche Bank Research senkt Ziel für Merck KGaA - 'Buy' (dpa-AFX) | |
31.01.25 |
Zuversicht in Frankfurt: LUS-DAX präsentiert sich mittags fester (finanzen.at) | |
31.01.25 |
Freundlicher Handel in Frankfurt: DAX fester (finanzen.at) | |
31.01.25 |
Merck-Aktie: Jüngste Einstufung durch Deutsche Bank AG (finanzen.at) |
Analysen zu Merck KGaAmehr Analysen
31.01.25 | Merck Buy | Deutsche Bank AG | |
20.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
17.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
09.01.25 | Merck Buy | Goldman Sachs Group Inc. | |
07.01.25 | Merck Market-Perform | Bernstein Research |
Aktien in diesem Artikel
Merck KGaA | 146,10 | -3,25% |
Indizes in diesem Artikel
S&P 500 | 6 040,53 | -0,50% |